CH572905A5 - Sulphamido-aralkylamine cpds - with vasodilatory, cardiac-stimulant, blood-pressure, and broncholytic activity - Google Patents
Sulphamido-aralkylamine cpds - with vasodilatory, cardiac-stimulant, blood-pressure, and broncholytic activityInfo
- Publication number
- CH572905A5 CH572905A5 CH1390275A CH1390275A CH572905A5 CH 572905 A5 CH572905 A5 CH 572905A5 CH 1390275 A CH1390275 A CH 1390275A CH 1390275 A CH1390275 A CH 1390275A CH 572905 A5 CH572905 A5 CH 572905A5
- Authority
- CH
- Switzerland
- Prior art keywords
- cpds
- blood
- sulphamido
- aralkylamine
- vasodilatory
- Prior art date
Links
- 230000000304 vasodilatating effect Effects 0.000 title abstract 3
- 230000036772 blood pressure Effects 0.000 title abstract 2
- 230000001813 broncholytic effect Effects 0.000 title 1
- 239000000496 cardiotonic agent Substances 0.000 title 1
- 125000000217 alkyl group Chemical group 0.000 abstract 3
- ZZUFCTLCJUWOSV-UHFFFAOYSA-N furosemide Chemical compound C1=C(Cl)C(S(=O)(=O)N)=CC(C(O)=O)=C1NCC1=CC=CO1 ZZUFCTLCJUWOSV-UHFFFAOYSA-N 0.000 abstract 2
- 239000002253 acid Substances 0.000 abstract 1
- 125000003710 aryl alkyl group Chemical group 0.000 abstract 1
- 125000003118 aryl group Chemical group 0.000 abstract 1
- 125000005160 aryl oxy alkyl group Chemical group 0.000 abstract 1
- 239000000168 bronchodilator agent Substances 0.000 abstract 1
- 230000000747 cardiac effect Effects 0.000 abstract 1
- 239000003795 chemical substances by application Substances 0.000 abstract 1
- 239000003814 drug Substances 0.000 abstract 1
- 125000000623 heterocyclic group Chemical group 0.000 abstract 1
- 230000003287 optical effect Effects 0.000 abstract 1
- 230000002093 peripheral effect Effects 0.000 abstract 1
- ISWSIDIOOBJBQZ-UHFFFAOYSA-N phenol group Chemical group C1(=CC=CC=C1)O ISWSIDIOOBJBQZ-UHFFFAOYSA-N 0.000 abstract 1
- 150000003839 salts Chemical class 0.000 abstract 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C303/00—Preparation of esters or amides of sulfuric acids; Preparation of sulfonic acids or of their esters, halides, anhydrides or amides
- C07C303/36—Preparation of esters or amides of sulfuric acids; Preparation of sulfonic acids or of their esters, halides, anhydrides or amides of amides of sulfonic acids
- C07C303/40—Preparation of esters or amides of sulfuric acids; Preparation of sulfonic acids or of their esters, halides, anhydrides or amides of amides of sulfonic acids by reactions not involving the formation of sulfonamide groups
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D207/00—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom
- C07D207/02—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
- C07D207/30—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having two double bonds between ring members or between ring members and non-ring members
- C07D207/34—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having two double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D207/36—Oxygen or sulfur atoms
- C07D207/40—2,5-Pyrrolidine-diones
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
- A61P11/08—Bronchodilators
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/08—Vasodilators for multiple indications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D295/00—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms
- C07D295/22—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with hetero atoms directly attached to ring nitrogen atoms
- C07D295/26—Sulfur atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D473/00—Heterocyclic compounds containing purine ring systems
- C07D473/02—Heterocyclic compounds containing purine ring systems with oxygen, sulphur, or nitrogen atoms directly attached in positions 2 and 6
- C07D473/04—Heterocyclic compounds containing purine ring systems with oxygen, sulphur, or nitrogen atoms directly attached in positions 2 and 6 two oxygen atoms
- C07D473/06—Heterocyclic compounds containing purine ring systems with oxygen, sulphur, or nitrogen atoms directly attached in positions 2 and 6 two oxygen atoms with radicals containing only hydrogen and carbon atoms, attached in position 1 or 3
- C07D473/08—Heterocyclic compounds containing purine ring systems with oxygen, sulphur, or nitrogen atoms directly attached in positions 2 and 6 two oxygen atoms with radicals containing only hydrogen and carbon atoms, attached in position 1 or 3 with methyl radicals in positions 1 and 3, e.g. theophylline
-
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
- Y02P—CLIMATE CHANGE MITIGATION TECHNOLOGIES IN THE PRODUCTION OR PROCESSING OF GOODS
- Y02P20/00—Technologies relating to chemical industry
- Y02P20/50—Improvements relating to the production of bulk chemicals
- Y02P20/55—Design of synthesis routes, e.g. reducing the use of auxiliary or protecting groups
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Engineering & Computer Science (AREA)
- Public Health (AREA)
- Animal Behavior & Ethology (AREA)
- General Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Pharmacology & Pharmacy (AREA)
- Veterinary Medicine (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Life Sciences & Earth Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Heart & Thoracic Surgery (AREA)
- Cardiology (AREA)
- Pulmonology (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Peptides Or Proteins (AREA)
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
DE2115926A DE2115926C3 (de) | 1971-04-01 | 1971-04-01 | 1 -(4-Hydroxy-3-dimethylaminosuIfamidophenyI)-2-aminoäthanderivate, Verfahren zu ihrer Herstellung und diese enthaltende Mittel |
CH482372A CH587236A5 (fr) | 1971-04-01 | 1972-03-30 |
Publications (1)
Publication Number | Publication Date |
---|---|
CH572905A5 true CH572905A5 (en) | 1976-02-27 |
Family
ID=5803592
Family Applications (6)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CH1056976A CH590219A5 (fr) | 1971-04-01 | 1972-03-30 | |
CH1390475A CH580069A5 (fr) | 1971-04-01 | 1972-03-30 | |
CH1390275A CH572905A5 (en) | 1971-04-01 | 1972-03-30 | Sulphamido-aralkylamine cpds - with vasodilatory, cardiac-stimulant, blood-pressure, and broncholytic activity |
CH1647576A CH587237A5 (fr) | 1971-04-01 | 1972-03-30 | |
CH1390375A CH580068A5 (fr) | 1971-04-01 | 1972-03-30 | |
CH482372A CH587236A5 (fr) | 1971-04-01 | 1972-03-30 |
Family Applications Before (2)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CH1056976A CH590219A5 (fr) | 1971-04-01 | 1972-03-30 | |
CH1390475A CH580069A5 (fr) | 1971-04-01 | 1972-03-30 |
Family Applications After (3)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CH1647576A CH587237A5 (fr) | 1971-04-01 | 1972-03-30 | |
CH1390375A CH580068A5 (fr) | 1971-04-01 | 1972-03-30 | |
CH482372A CH587236A5 (fr) | 1971-04-01 | 1972-03-30 |
Country Status (20)
Country | Link |
---|---|
US (1) | US4038314A (fr) |
JP (3) | JPS5735193B1 (fr) |
AR (6) | AR204905A1 (fr) |
AT (7) | AT327173B (fr) |
AU (1) | AU470838B2 (fr) |
BE (1) | BE781542A (fr) |
CH (6) | CH590219A5 (fr) |
DE (1) | DE2115926C3 (fr) |
DK (1) | DK140836B (fr) |
ES (4) | ES401332A1 (fr) |
FI (1) | FI58325C (fr) |
FR (1) | FR2132372B1 (fr) |
GB (1) | GB1381184A (fr) |
IE (1) | IE36240B1 (fr) |
IL (1) | IL39110A (fr) |
NL (1) | NL170850C (fr) |
NO (1) | NO135247C (fr) |
PH (1) | PH14121A (fr) |
SE (1) | SE393106B (fr) |
ZA (1) | ZA722177B (fr) |
Families Citing this family (14)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
GB1435721A (en) * | 1972-05-18 | 1976-05-12 | Lilly Industries Ltd | Benzoxazole derivatives |
CA1147342A (fr) * | 1977-10-12 | 1983-05-31 | Kazuo Imai | Procede de preparation de nouveaux derives de la phenylethanolamine |
JPS56110665A (en) * | 1980-02-08 | 1981-09-01 | Yamanouchi Pharmaceut Co Ltd | Sulfamoyl-substituted phenetylamine derivative and its preparation |
US4558156A (en) * | 1980-02-08 | 1985-12-10 | Yamanouchi Pharmaceutical Co., Ltd. | Sulfamoyl-substituted phenethylamine derivatives |
DE3220598A1 (de) * | 1982-06-01 | 1983-12-01 | Boehringer Ingelheim KG, 6507 Ingelheim | Lipolytische zusammensetzungen und mittel zur behandlung der fettsucht |
GB8322178D0 (en) * | 1983-08-17 | 1983-09-21 | Sterwin Ag | Preparing aerosol compositions |
GB8502892D0 (en) * | 1985-02-05 | 1985-03-06 | Sterwin Ag | Aerosol composition |
NZ226934A (en) * | 1987-11-13 | 1991-01-29 | Glaxo Group Ltd | Phenethanolamine derivatives and pharmaceutical compositions |
US20040127733A1 (en) | 2002-10-31 | 2004-07-01 | Boehringer Ingelheim Pharma Gmbh & Co. Kg | New beta-agonists, processes for preparing them and their use as pharmaceutical compositions |
DE10251170A1 (de) * | 2002-10-31 | 2004-05-13 | Boehringer Ingelheim Pharma Gmbh & Co. Kg | Neue Beta-Agonisten, Verfahren zu deren Herstellung und deren Verwendung als Arzneimittel |
DE102004021779A1 (de) | 2004-04-30 | 2005-11-24 | Boehringer Ingelheim Pharma Gmbh & Co. Kg | Neue Beta-Agonisten, Verfahren zu deren Herstellung und deren Verwendung als Arzneimittel |
DE102005052127A1 (de) | 2005-10-28 | 2007-05-03 | Boehringer Ingelheim Pharma Gmbh & Co. Kg | Neue indol-haltige Beta-Agonisten, Verfahren zu deren Herstellung und deren Verwendung als Arzneimittel |
US7718822B2 (en) * | 2007-08-28 | 2010-05-18 | Sepracor Inc. | Carbamate Stereoisomer |
CN109535007A (zh) * | 2018-11-07 | 2019-03-29 | 万华化学集团股份有限公司 | 一种二氨基二环己基甲烷同分异构体分离方法 |
Family Cites Families (5)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US3804834A (en) * | 1967-10-16 | 1974-04-16 | Boehringer Sohn Ingelheim | 1-(2',3',4'-trisubstituted-phenyl)-2-amino-alkanols-(1)and salts thereof |
US3701808A (en) * | 1967-12-21 | 1972-10-31 | Allen & Hanburys Ltd | Phenylethanolamines |
US3574741A (en) * | 1969-04-14 | 1971-04-13 | Mead Johnson & Co | Sulfonamidophenalkylamines |
US3711545A (en) * | 1971-02-23 | 1973-01-16 | Smith Kline French Lab | Alpha-aminoalkyl-4-hydroxy-3-sulfamoylaminobenzyl alcohols |
BE794414A (fr) * | 1972-01-25 | 1973-07-23 | Sandoz Sa | Nouveaux amino-alcools, leur preparation et leur application comme medicament |
-
1971
- 1971-04-01 DE DE2115926A patent/DE2115926C3/de not_active Expired
-
1972
- 1972-01-01 AR AR244859A patent/AR204905A1/es active
- 1972-03-28 NO NO1061/72A patent/NO135247C/no unknown
- 1972-03-29 PH PH13398A patent/PH14121A/en unknown
- 1972-03-29 IL IL39110A patent/IL39110A/xx unknown
- 1972-03-29 DK DK154772AA patent/DK140836B/da not_active IP Right Cessation
- 1972-03-29 ES ES401332A patent/ES401332A1/es not_active Expired
- 1972-03-30 IE IE415/72A patent/IE36240B1/xx unknown
- 1972-03-30 CH CH1056976A patent/CH590219A5/xx not_active IP Right Cessation
- 1972-03-30 CH CH1390475A patent/CH580069A5/xx not_active IP Right Cessation
- 1972-03-30 CH CH1390275A patent/CH572905A5/xx not_active IP Right Cessation
- 1972-03-30 GB GB1515672A patent/GB1381184A/en not_active Expired
- 1972-03-30 CH CH1647576A patent/CH587237A5/xx not_active IP Right Cessation
- 1972-03-30 AU AU40592/72A patent/AU470838B2/en not_active Expired
- 1972-03-30 SE SE7204239A patent/SE393106B/xx unknown
- 1972-03-30 ZA ZA722177A patent/ZA722177B/xx unknown
- 1972-03-30 FI FI915/72A patent/FI58325C/fi active
- 1972-03-30 CH CH1390375A patent/CH580068A5/xx not_active IP Right Cessation
- 1972-03-30 CH CH482372A patent/CH587236A5/xx not_active IP Right Cessation
- 1972-03-30 NL NLAANVRAGE7204316,A patent/NL170850C/xx not_active IP Right Cessation
- 1972-03-31 JP JP3180472A patent/JPS5735193B1/ja active Pending
- 1972-03-31 AT AT915074*7A patent/AT327173B/de not_active IP Right Cessation
- 1972-03-31 AT AT00895/74A patent/AT320613B/de not_active IP Right Cessation
- 1972-03-31 AT AT284472A patent/AT326628B/de not_active IP Right Cessation
- 1972-03-31 BE BE781542A patent/BE781542A/fr not_active IP Right Cessation
- 1972-03-31 AT AT89474*A patent/AT321888B/de not_active IP Right Cessation
- 1972-03-31 AT AT915174*7A patent/AT327174B/de active
- 1972-03-31 FR FR7211614A patent/FR2132372B1/fr not_active Expired
- 1972-03-31 AT AT915174*1A patent/ATA915174A/de unknown
- 1972-10-27 AR AR244860A patent/AR200116A1/es active
- 1972-10-27 AR AR244858A patent/AR200002A1/es active
-
1973
- 1973-10-25 ES ES419934A patent/ES419934A1/es not_active Expired
- 1973-10-25 ES ES419936A patent/ES419936A1/es not_active Expired
- 1973-10-25 ES ES419935A patent/ES419935A1/es not_active Expired
- 1973-11-26 AR AR251170A patent/AR210055A1/es active
- 1973-11-26 AR AR251169A patent/AR199809A1/es active
- 1973-11-26 AR AR251171A patent/AR209268A1/es active
-
1974
- 1974-03-21 US US05/453,438 patent/US4038314A/en not_active Expired - Lifetime
- 1974-03-31 AT AT89674*A patent/AT321889B/de not_active IP Right Cessation
-
1981
- 1981-05-25 JP JP56078169A patent/JPS5929190B2/ja not_active Expired
- 1981-05-25 JP JP56078170A patent/JPS5929191B2/ja not_active Expired
Also Published As
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CH572905A5 (en) | Sulphamido-aralkylamine cpds - with vasodilatory, cardiac-stimulant, blood-pressure, and broncholytic activity | |
NO152130C (no) | Analogifremgangsmaate for fremstilling av bronchospasmolytisk virksomme forbindelser | |
ES532741A0 (es) | Procedimiento de preparar compuestos beta-lactamicos | |
ES436311A1 (es) | Procedimiento para la preparacion de nuevos 1-ariloxi-2-hi- droxi-3-alquinilaminopropanos. | |
GB1379790A (en) | Process for producing 7-acylamido-3-cephem-4-carboxylic acids | |
ES8300104A1 (es) | Un procedimiento para obtener derivados de benzopirano | |
ATE98128T1 (de) | Verfahren zur behandlung der herzinsuffizienz. | |
SE390108B (sv) | Dialysanordning for rening av ett medium, foretredesvis blod | |
ES2196000T3 (es) | Compuesto de pirroloazepina. | |
FR2230376A1 (en) | Stable solutions of siloxanic polysilanols - prepd. by hydrolysis of a silane and having pharmaceutical activity | |
FR2378757A1 (fr) | Nor-o-heterocyclo-dehydro-13, 14 prostaglandines, leur procede de preparation et leur application comme medicaments | |
DK299981A (da) | Fremgangsmaade til fremstilling af 1-s-alkyl-2-0-acyl-3-phosphocolin-1-mercapto-2.3-propandioler | |
FR2432502A1 (fr) | Acides amino-alcanoiques substitues, leur utilisation, leur preparation et medicaments en contenant | |
FR2390954A1 (fr) | Nouvelles guanylhydrazones, leurs procedes de preparation et medicaments les contenant | |
SU369889A1 (ru) | Дефолиант | |
ES388561A1 (es) | Procedimiento para la preparacion de compuestos derivados de aminoetanol. | |
ES408929A1 (es) | Procedimiento para preparar derivados de decahidroquinoli- noles sustituidos. | |
ES402285A1 (es) | Procedimiento para la obtencion de composiciones farmaceu- ticas con actividad fibrinolitica o antifibrinolitica. | |
FR2226173A1 (en) | 1-Amino-3-(cyclopropa (b) napthoxy)-2-propanols - as anti-arrhythmics, prepd. by aminating corresp. epoxides | |
AT316515B (de) | Verfahren zur Herstellung des neuen racemischen oder optisch aktiven 1-(2',5'-Dichlorphenoxy)-2-hydroxy-3-tert. butylaminopropans und dessen Säureadditionssalze | |
GB1504604A (en) | 1- (aralkoxyphenyl) - 2- or -3 - (bis - arylalkylamino)-alkanes process for their manufacture and pharmaceutical preparations containing them | |
JPS5515481A (en) | Heart pulse decreasing agent | |
ES419044A1 (es) | Procedimiento para preparar nuevos derivados del 1,4-benzo-dioxano. | |
FR2397401A1 (fr) | Esters carboxymethyliques d'acides mercaptopropanoiques, et leur utilisation therapeutique | |
ES8406488A3 (es) | Procedimiento para la preparacion de derivados de norescopolamina racemicos u opticamente activos. |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
PL | Patent ceased |